研究人员为儿科脑肿瘤开发新的以免疫为重点的诊断,而CAR-T疗法显示出希望。 Researchers develop new immune-focused diagnostic for pediatric brain tumors, and CAR-T therapy shows promise.

研究人员为儿科脑肿瘤开发了一个新的诊断平台,侧重于人体的免疫反应,有可能导致量身定制的治疗。 Researchers have developed a new diagnostic platform for pediatric brain tumors that focuses on the body's immune response, potentially leading to tailored treatments. 在不同的试验中,最初针对血癌的CAR-T疗法在治疗儿科脑肿瘤方面表现出了希望,有些病人的存活时间比预期的长得多。 In separate trials, CAR-T therapy, originally for blood cancers, showed promise in treating pediatric brain tumors, with some patients surviving much longer than expected. 然而,还需要开展更多的研究,以证实这些结果,克服固态肿瘤和血脑屏障特有的挑战。 However, more research is needed to confirm these results and overcome challenges specific to solid tumors and the blood-brain barrier.